This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kyran P. Quinlan, MD; Karen Hayani, MD
Department of Pediatrics University of Chicago 950 E 61st St Chicago, IL 60637

Arch Pediatr Adolesc Med. 1996;150(8):882.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

With concern about vitamin A toxic side effects, Dr Donnelly wonders if the children with respiratory syncytial virus infection in our study¹ would have benefited more if we had given them β-carotene, a vitamin A precursor, rather than vitamin A solution. We found that a onetime oral administration of 100 000IU of vitamin A for 21 inpatient children infected with respiratory syncytial virus did not provide any measurable clinical benefit or cause vitamin A toxic effects. The dose of vitamin A in our study was based on the World Health Organization–United Nations International Children's Emergency Fund recommendations for the use of vitamin A for measles.² Evidence from African studies^3-5 have shown that vitamin A, not β-carotene, benefits patients with measles. The mean serum retinol levels in children with acute measles infection in those studies were approximately half of that in the US children with respiratory syncytial virus . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?